Next Article in Journal
Association Between the Dietary Index for Gut Microbiota (DI-GM) and Colorectal Cancer in the PLCO Cohort
Previous Article in Journal
The Flavonoid Apigenin Modulates Oligodendroglial Plasticity and Has a Neuroprotective Effect in Cerebellar Slice Cultures with Oxygen Glucose Deprivation
Previous Article in Special Issue
European Bilberry Extract Ameliorates Dietary Advanced Glycation End Products-Induced Non-Alcoholic Steatohepatitis in Rats via Gut Microbiota and Its Metabolites
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dietary Patterns, Hepatic Fat Fraction, and the Role of Genotype

1
Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
2
Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO 80045, USA
3
Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
4
Department of Epidemiology, School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
5
Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA
*
Author to whom correspondence should be addressed.
Nutrients 2026, 18(7), 1087; https://doi.org/10.3390/nu18071087
Submission received: 29 January 2026 / Revised: 9 March 2026 / Accepted: 25 March 2026 / Published: 28 March 2026

Abstract

Background/Objectives: We aimed to identify eating habits associated with hepatic fat fraction (HFF) and assess effect modification by an established genetic variant for fatty liver disease, PNPLA3 rs738409, among 381 general-risk adolescents. Methods: Dietary intake was assessed using the Block Kids Food Frequency Questionnaire and HFF was measured via magnetic resonance imaging (MRI) at age ~16 years. We first characterized naturally occurring dietary patterns using principal component analysis followed by reduced-rank regression with HFF as the response variable to identify a dietary pattern that is both relevant to the population and associated with HFF. Next, we investigated associations of the dietary pattern with HFF using linear regression models that accounted for maternal gestational diabetes, education, and prenatal smoking and child sex, age, Tanner stage, and BMI. Finally, we tested for a dietary pattern and PNPLA3 rs738409 interaction and stratified by genotype if P-interaction < 0.05. Results: The participants were 16.7 ± 1.2 years (range: 12.6–19.6 years). Half were female (50.4%) and 52.0% identified as non-Hispanic White. The dietary pattern of interest was composed of vegetables, fruit, nuts and seeds, oatmeal, sports bars, crackers and sandwiches, and beef, and was inversely associated with HFF (−0.48 [95% CI: −0.81, −0.16]). Stratified analyses revealed the strongest inverse association observed between the diet pattern score and HFF in the high-risk-variant (GG) group (−2.19 [−4.35, −0.03]), followed by the intermediate-risk (CG) group (−0.43 [−0.77, −0.10]), but not the low-risk (CC) group (−0.32 [−0.77, 0.13]). Conclusions: A diet high in vegetables, fruit, nuts and seeds, oatmeal, sports bars, crackers and sandwiches, and beef—potentially capturing an active, on-the-go lifestyle—is associated with lower HFF during adolescence, especially among individuals at genetic risk.

1. Introduction

Hepatic fat fraction (HFF) is a measurement of how much fat is present in the liver. HFF is commonly used to evaluate the risk of fatty liver disease, ranging from mild steatosis to advanced metabolic dysfunction-associated steatotic liver disease (MASLD), the most common chronic liver disease worldwide [1]. The rise of the childhood obesity epidemic has contributed to an increase in MASLD prevalence among children and adolescents, now affecting approximately 10% of the general pediatric population and up to 35% of youth with obesity [2].
The causes of MASLD are complex [3] and likely involve gene-by-environment interactions. Specifically, the GG variant of the PNPLA3 rs738409 genotype has been linked to liver fat accumulation, hepatic inflammation, steatohepatitis, and fibrosis and cirrhosis [4]. Given the absence of approved pharmacological treatments for MASLD in pediatric populations, lifestyle modifications remain the primary strategy for managing youth-onset MASLD [5,6].
Several studies have linked dietary habits to risk of MASLD. In adults, a recent systematic review highlights that intake of refined carbohydrates and unhealthy fats are consistently associated with risk of MASLD [7]. Conversely, both observational studies and clinical trials have demonstrated that adherence to a Mediterranean-style or “prudent” diet characterized by high consumption of polyunsaturated fats, fresh fruits, vegetables, and dietary fiber is protective against MASLD [8]. However, a limitation of the current literature is the predominant use of unsupervised approaches to characterize dietary patterns and/or derivation of a priori diet indices (e.g., Healthy Eating Index, Mediterranean Diet Score) that have varying degrees of relevance to the study population.
In the Exploring Perinatal Outcomes among CHildren (EPOCH) cohort, a cohort of general-risk adolescents in Denver, CO, we identified two dietary patterns prospectively and cross-sectionally associated with hepatic fat fraction (HFF) using principal component analysis (PCA), an unsupervised dimension-reduction approach that characterizes data-driven, naturally occurring dietary patterns. Adherence to a “prudent” dietary pattern, characterized by high fruit and vegetable intake, was associated with lower HFF among all youth. In contrast, adherence to a Western dietary pattern was associated with higher HFF, but this association was observed only among non-Hispanic White youth [9].
We now seek to build upon our prior work by using both PCA and reduced-rank regression (RRR), a supervised dimension-reduction technique, to identify dietary patterns that are both contextually relevant and associated with HFF and, accordingly, fatty liver disease. In addition, given the known gene-by-environment interactions involved in shaping risk of MASLD, we assessed the PNPLA3 rs738409 genotype as an effect modifier. We hypothesized that the integrated PCA-RRR approach would identify a dietary pattern that is both culturally relevant and associated with HFF and that associations of the dietary pattern with HFF and MASLD would differ by PNPLA3 rs738409 genotype.

2. Materials and Methods

2.1. Study Population

Study participants were from the Exploring Perinatal Outcomes among CHildren (EPOCH) study, a historical prospective cohort that sought to understand the long-term consequences and mechanisms linking in utero overnutrition to the development of metabolic risk across childhood and adolescence. In total, 604 children (N = 99 children exposed to maternal diabetes; N = 505 a random sample of unexposed youth) aged 6–13 years and their mothers were enrolled in the EPOCH study between 2006 and 2010. The offspring returned for clinical research visits at ages ~10 (range: 6.0–13.9 years) and ~16 years (range: 12.6 to 19.6 years), during which we collected data on sociodemographic characteristics, anthropometry, and lifestyle behaviors, and collected fasting blood. At the adolescent visit, we also conducted magnetic resonance imaging (MRI) scans to assess HFF.
This paper focused on data collected at the mid-to-late adolescent visit when HFF was measured. Of the 417 participants who attended the adolescent research visit, we excluded 18 participants due to missing data on HFF and 18 participants without data on dietary intake, yielding an analytic sample of 381 youth. The study protocol was approved by the Colorado Multiple Institutional Review Board. Informed consent was obtained from mothers and written assent was obtained from their offspring.

2.2. Dietary Assessment (Exposure)

The Block Kids Food Frequency Questionnaire (FFQ) [10] assesses how often 83 different foods were consumed over the past week, with response options to indicate how often each food or beverage was consumed ranging from “once a day” to “every day.”
Subsequently, the 83 food items were consolidated into 42 food groups based on their nutritional properties [9]. Total daily energy intake was estimated using the United States Department of Agriculture Food Composition Database [11] and each food group was energy-adjusted using the residuals method [9,12]. We used this data to characterize dietary patterns of interest, described in the Section 3.

2.3. Assessment of Hepatic Fat Fraction (Outcome)

Hepatic imaging was performed at the adolescent study visit via MRI, using a modification of the Dixon method [13,14]. HFF was calculated from the mean pixel signal intensity data for each flip angle acquisition. In the analysis, we prioritized assessing HFF continuously, due to the small percentage of participants with elevated liver fat consistent with MASLD (7.6% with HFF ≥ 5%).

2.4. Genotyping (Potenital Effect Modifier)

Standard genotyping procedures were applied as previously detailed by Stanislawski et al., who examined genetic determinates of hepatic fat as a continuous measure within the same cohort [15]. In brief, DNA was isolated from stored peripheral venous blood using the QIAamp kit (Qiagen, Germantown, MD, USA) [16]. DNA quantification and purity were assessed using a NanoDrop spectrophotometer and a Qubit fluorometer (Thermo Scientific, Waltham, MA, USA).
Genotyping was completed in 2 batches: the first batch utilized the Illumina Infinium Omni2.5-8 v1.1 (Illumina, Inc., San Diego, CA, USA) BeadChip for 226 samples, and the second batch used the Illumina Multi-Ethnic Global Array v1.0 (Illumina, Inc.) for 130 samples. QA/QC and filtering were conducted using PLINK 1.9 (available at www.cog-genomics.org/plink/1.9 (accessed on 25 December 2025)), following protocols described previously [17]. Participants with ≥5% missing genotypes and single nucleotide polymorphisms with ≥2% missingness were excluded. Genetic data were then imputed to the 1000 Genomes Phase 3 (v5) multi-ethnic reference panel.
Principal component analysis of the genetic data was calculated to evaluate global ancestry, potential batch effects, and residual relatedness among directly genotyped single nucleotide polymorphisms that passed quality control thresholds on both platforms. In prior analyses of the EPOCH cohort [16], associations between a set of 5 single nucleotide polymorphisms (PNPLA3 rs738409, GCKR rs1260326, PPP1R3B rs4240624, LYPLAL1 rs12137855, and NCAN rs2228603) and adolescent hepatic fat were examined, with only the PNPLA3 risk allele demonstrating a significant association with hepatic fat content. Therefore, the present analysis focuses exclusively on the PNPLA3 rs738409 risk allele as a potential effect modifier in the relationship between dietary patterns and adolescent hepatic fat.

2.5. Covariates

Maternal pre-pregnancy body mass index (BMI; kg/m2) was derived from measured height and pre-pregnancy weight obtained from the medical record. As part of routine prenatal care, all women are routinely screened for gestational diabetes mellitus (GDM) at 24 to 28 weeks using the standard two-step protocol [9,18]. Mothers reported their education level and smoking habits during pregnancy via a questionnaire at study enrollment when the youth were ~9 years of age [19].
Children’s weight was measured on a digital scale and height was measured via a calibrated stadiometer at both research visits. BMI was calculated and standardized using the World Health Organization growth reference [20]. Youth reported their race/ethnicity at enrollment.
Pubertal development was measured at the adolescent study visit, based on Tanner stage of pubic hair development in boys and breast development in girls [21]. Physical activity was assessed at the adolescent study visit using the 3-Day Physical Activity Recall Questionnaire (3DPAR), which captures typical physical activity patterns over a three-day period [22] and has been validated against accelerometry [9,23]. Using 3DPAR, average energy expenditure was derived as a proxy for physical activity (mean metabolic equivalents [METs]/day over a 3-day period).

3. Data Analysis

3.1. Exploratory Analysis

We began by examining the univariate distributions of variables both for the overall study sample and stratified by PNPLA3 rs738409 genotype: CC—homozygous for the cytosine variant, which is considered the wild-type or normal/low-risk variant; CG—heterozygous, carrying one cytosine variant and one guanine variant, or intermediate-risk; GG—homozygous for the guanine variant, also known as the “risk” variant.
Next, we examined bivariate relationships between background characteristics and HFF. This step, combined with our prior knowledge of determinants of cardiometabolic health in youth, guided the selection of covariates for the multivariable analysis.

3.2. Creation of Dietary Patterns

Using data on dietary intake of 42 food groups, we created dietary patterns using principal component analysis (PCA) as previously described [9]. From the PCA results, we retained the first two factors based on standard criteria, including the Scree plot, eigenvalues > 1 [24], and interpretability [9]. Food groups with factor loadings ≥ |0.20| were considered to be meaningful contributors to a dietary pattern, per convention [25,26].
Using the same set of food groups, we then applied reduced-rank regression (RRR) and focused on the first factor as the dietary pattern, as this is the factor that most strongly predicts the response variable [27]. We then identified overlapping food groups between PCA factors and RRR Factor 1 based on factor loadings.
To derive the integrated PCA-RRR diet score, which represents an eating pattern that is both naturally occurring in this population and associated with HFF, we used RRR factor loadings to weight relevant PCA-identified food groups and took the average across the values. This score is normally distributed (mean ~ 0, SD ~ 1) and can be interpreted the same way dietary patterns are interpreted—i.e., a higher positive score indicates greater alignment of a participant’s eating patterns that are captured by the diet score, whereas a lower and negative score indicates the opposite.

3.3. Multivariable Analysis

In the main analysis, we examined associations of the PCA-RRR diet score with HFF using a series of multivariable linear regression models that sequentially adjusted for covariates based on temporality, prior knowledge, and the bivariate analysis. Model 1 included the child’s sex and age, which are standard covariates in all studies of child health outcomes given convention in studies of children’s health, and the centrality of these two variables in accounting for variation in both health behaviors and metabolic outcomes. Model 2 further accounted for perinatal determinants of offspring health, including in utero exposure to maternal GDM, maternal education level, and prenatal smoking habits. Finally, Model 3 accounted for Model 1 covariates plus child BMI z-score and Tanner stage. The rationale behind sequentially adjusting for covariates, as opposed to adjusting for them all at once, is to provide transparency in how the estimate of interest (i.e., the estimate for diet score in relation to HFF) changes across the models. Estimates that are stable in terms of direction, magnitude, and precision of effects provide support for true associations, as opposed to spurious results.
We ran all models using logistic regression to investigate associations of the diet score with elevated liver fat (HFF ≥ 5%) as a dichotomous variable.
In sensitivity analyses, we further adjusted for energy expenditure (METs), which correlates with dietary intake and is associated with metabolic health; as well as self-reported race/ethnicity, which captures sociocultural norms that may shape dietary intake and metabolic disease risk in Model 2.

3.4. PNPLA3 rs738409 Genotype

To assess effect modification by the PNPLA3 rs738409 genotype, we tested for an interaction between the number of copies of the G allele (0, 1, 2) and dietary pattern using Model 1 and subsequently conducted analysis stratified by genotype.
We carried out all analyses using SAS software (version 9.4; SAS Institute Inc., Cary, NC, USA). Across all models, we used alpha = 0.05 as the threshold for statistical significance, though we focused on the direction, magnitude, and precision of associations when interpreting results.

4. Results

Table 1 shows the study participant characteristics. At the adolescent visit, the average age was 16.7 ± 1.2 years (range: 12.6 to 19.6 years). Half of the participants were female (50.4%). Half (52.0%) of participants identified as non-Hispanic White, 36.0% as Hispanic, 7.4% as non-Hispanic Black, and 4.7% as non-Hispanic Other. More than half of participants (67.2%) were of normal weight. The average HFF was 2.5% (median: 1.9%; range: 0% to 38.2%) and 7.6% (n = 29) had elevated liver fat consistent with MASLD.
In Supplemental Table S1, we show maternal perinatal and child characteristics among 330 mother–child pairs in the EPOCH study, stratified by PNPLA3 rs738409 genotype variant. As expected, both BMI and HFF are highest in the GG variant group, though the differences are statistically significant only for HFF. Participants with the high-risk variant (GG allele) were also most likely to be of Hispanic ethnicity.
Table 2 shows bivariate associations of the background characteristics with HFF. Higher maternal pre-pregnancy BMI (P-for-trend = 0.0001), lower annual household income (P-difference = 0.02), higher BMI z-score at the adolescent study visit (P-for-trend < 0.0001), and more advanced Tanner stage were each associated with higher HFF at median age 16 years.
Table 3 shows the composition of dietary patterns we retained from the PCA and the first factor of RRR. In the PCA, we retained two factors. As previously identified in a slightly different subset of this cohort, Factor 1 captured a prudent dietary pattern composed of leafy greens, vegetables, fruit, cruciferous vegetables, and nuts and seeds; and Factor 2 is a Western dietary pattern, composed of fried potatoes, ketchup, beef, and cereal.
Factor 1 from the RRR was driven primarily by Mediterranean-diet-like foods such as vegetables, fruit, nuts and seeds, but also included sports bars, crackers and sandwiches, and beef. Together, we interpret this pattern as a relatively healthy and “active/on-the-go” dietary pattern. The weighted diet score comprised the following food groups from PCA factor 1: vegetables, fruit, nuts and seeds, oatmeal, sports bars, crackers and sandwiches, and beef.
Table 4 shows the association of the PCA-RRR diet score with HFF in the overall study sample. This dietary pattern was inversely associated with both continuous HFF and the odds of elevated HFF, consistent with MASLD. After adjusting for the participants’ age and sex, each 1-unit increment of the diet score corresponded with a 0.48% lower HFF (95% CI: −0.80, −0.16; Model 1). Additional adjustment for perinatal characteristics in Model 2 did not change the estimate. However, adjusting for the participants’ concurrent BMI z-score and Tanner stage in Model 3 attenuated the estimate by ~20%, as expected given that these variables are potential mediators on the causal pathway between diet and HFF, though the estimate remained statistically significant. Similarly, each 1-unit increment of the diet score was associated with 0.46 times the odds of elevated HFF, indicative of MASLD (95% CI: 0.27, 0.78; Model 1), with little change in estimates across subsequent multivariable models.
Table 5 shows results of the analysis stratified by PNPLA3 rs738409 genotype. In unadjusted models within strata of GG (high-risk), CG (intermediate-risk), and CC (wild-type; low-risk), the inverse association of the diet score with HFF was greatest among participants with the high risk genotype (β: −2.19, 95% CI: −4.35, −0.03), followed by the intermediate (β: −0.43, 95% CI: −0.77, −0.10). We noted weak and null association in the low-risk group. Covariate adjustment attenuated some estimates to the null, which is, in part, an artifact of smaller sample size as the patterns and trends remained apparent. We observed similar associations of the strongest protective effects among individuals with the highest genetic risk when assessing HFF as a binary variable, in accordance with the threshold indicative of MASLD.
In all models, neither adjustment for total energy expenditure (METs) nor adjustment for race/ethnicity changed the findings.

5. Discussion

In this study, we applied both unsupervised (PCA) and supervised (RRR) dimension-reduction techniques to dietary data to characterize a dietary pattern that is both naturally occurring and associated with HFF among general-risk youth in the EPOCH study (n = 381). The dietary pattern—which we posit captures an active/on-the-go lifestyle—comprised vegetables, fruit, nuts and seeds, oatmeal, sports bars, crackers and sandwiches, and beef and was inversely associated with HFF and odds of elevated HFF indicative of MASLD. Further, the inverse association of this dietary pattern was most prominent among individuals with the high-risk PNPLA3 rs738409 variant (GG), suggesting specific dietary modifications and habits that may be particularly beneficial among individuals who are genetically predisposed to fatty liver disease.

5.1. Associations of the Dietary Pattern with HFF

The top-loading foods in the PCA-RRR dietary pattern included vegetables, fruit, nuts and seeds, which are key components of prudent and Mediterranean-style diets that are consistently associated with lower HFF in diverse populations of youth [28,29,30] and adults [31], and with results of a 2021 recent systematic review and meta-analysis [32]. To include a few examples from the literature, in a study of 243 Italian adolescents with obesity, poor adherence to a Mediterranean diet was associated with severity of non-alcoholic fatty liver disease [28]. In a study among 181 Turkish children with obesity both with and without fatty liver disease, as well as healthy controls, those with fatty liver disease had the lowest compliance with a Mediterranean-style diet, followed by children with obesity without fatty liver disease, followed by healthy children who demonstrated the highest adherence to a Mediterranean diet [29]. Similarly, in a cross-sectional study of 175 Latino youth aged 8–18 years who were overweight, those who consumed the most non-starchy vegetables had 44% less liver fat than those who consumed the least non-starchy vegetables and those who consumed nutrient-rich vegetables had 17% less visceral adipose tissue compared to those who did not consume nutrient-rich vegetables [30].
Of note, the dietary pattern that we identified in this study includes foods that do not typically align with a prudent or Mediterranean-style dietary pattern, such as sports bars and crackers and sandwiches, some of which are classified as ultra-processed foods. While processed foods have been linked to negative health outcomes, including poor metabolic health [33,34,35,36], some such foods—i.e., sports bars or other packaged foods marketed as being energy- or macronutrient-dense—may reflect an active lifestyle that takes advantage of packaged foods, in moderation, for their convenient and energy-dense nature, to meet higher nutritional demands and they may confer some degree of protection against metabolic conditions like MASLD [37,38], whether directly or via higher physical activity levels. While this interpretation of this dietary pattern requires further exploration and confirmation via both qualitative and quantitative analyses, it aligns with some published findings. For example, a cross-sectional study of 1438 adolescents from public schools in Brazil found that adherence to a “snacking” dietary pattern, which included processed meats, breads, crackers, and cheese, was observed among more physically active individuals [39]. Additionally, a qualitative study among Division I college athletes (n = 14, 64% female) from a variety of sports found that athletes reported commonly consuming sports bars due to them being convenient and quick fuel [40]. Additionally, common ingredients in sports bars such as protein may offer benefits for prevention and management of such diseases [41]. Ultimately, given the unfavorable long-term consequences of regular ultra-processed food consumption, additional research is needed and our findings should be interpreted cautiously.

5.2. Effect Modification by PNPLA3 rs738409 Genotype

We found evidence of effect modification by the PNPLA3 rs738409 genotype. Specifically, the strongest inverse association with dietary pattern was observed in participants with two copies of the risk (G) allele. Such findings suggest that healthful dietary and/or lifestyle modifications may be particularly beneficial for those genetically predisposed to fatty liver disease. In alignment with other multi-ethnic studies [42,43,44,45], EPOCH participants with the high-risk variant of PNPLA3 rs738409 were also most likely to be of Hispanic ethnicity, thereby driving associations between diet and hepatic fat. As this co-occurrence reflects the true population distribution of the PNPLA3 rs738409 genotype by race/ethnicity, our findings serve as a foundation for future studies to further investigate specific approaches to preventing MASLD among Hispanic youth.
These findings align with those from a study of 114 Latino adolescents, which observed that the relationship of dietary sugars with liver stiffness, a subclinical indicator of MASLD risk, was strongest among participants with two copies of the risk (G) allele [45]. On the other hand, a recent randomized controlled trial among 105 Latino youth with obesity found that a clinical intervention to reduce dietary sugar did not improve liver outcomes, regardless of PNPLA3 rs738409 genotype [46]. However, this study only focused on one component of diet (sugary beverages) as opposed to a comprehensive assessment of overall diet, which may explain why the results were null. Further research should aim to better understand the role of the PNPLA3 rs738409 genotype in the relationships between more comprehensive aspects of diet quality and liver outcomes in youth and adolescents, with and without obesity.

5.3. Strengths and Limitations

Our study had several strengths. First, the comprehensive data on confounders and precision covariates substantially improved our ability to make inferences regarding the potential influence of diet on liver fat content. Second, we derived a diet score that contains foods that are both contextually relevant (via PCA) and relevant to HFF (via RRR), which allowed us to identify realistic eating patterns that most strongly predict HFF. Lastly, we considered the role of an established genetic variant (PNPLA3 rs738409) associated with obesity-related diseases including fatty liver disease as an effect modifier, which allowed us to better understand heterogeneity in the pathophysiology of fatty liver disease development.
The limitations of this study include the potential for recall bias in dietary intake and residual confounding by environmental and lifestyle characteristics. Further, this study did not use the gold standard of a liver biopsy to measure liver fat content, which limits clinically relevant disease staging and interpretation of severity. However, the EPOCH study used MRI to measure liver fat, which is the most sensitive non-invasive procedure available. The cross-sectional study design of this analysis limits causal inference between diet and hepatic fat, though given that the majority of participants did not meet clinical thresholds of HFF consistent with MASLD and the general-risk nature of this population, it is unlikely that HFF levels would have led to changes to dietary habits. The relatively small sample size, especially within strata of PNPLA3 polymorphisms, for which only 30 individuals had the high-risk genotype, may limit the statistical power to detect associations, reduce the generalizability of the findings (especially given that EPOCH participants were recruited only from the state of Colorado), and increase susceptibility to selection bias.

6. Conclusions

In this analysis of 381 diverse adolescents, compliance with a diet comprising vegetables, fruit, nuts and seeds, oatmeal, sports bars, crackers and sandwiches, and beef was associated with lower HFF and lower odds of elevated HFF currently used as part of the diagnostic criteria for MASLD, especially among youth with a high-risk genotype. While we cannot state with certainty that the “protective” effect of the dietary pattern on the risk of fatty liver disease is causal or reflective of other health behaviors, our findings reinforce the potential utility of strategies to promote healthy lifestyles to interrupt disease progression at early, modifiable phases of the liver disease continuum and the particular benefit of doing so among individuals with a genetic predisposition for metabolic disease. Further, as cardiometabolic disease risk factors track from youth into adulthood [47], our findings support the potential importance of childhood and adolescence as important life stages to mount preventive action, especially among high-risk individuals who may particularly benefit from healthy lifestyle modifications.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/nu18071087/s1, Table S1: % (N) for maternal perinatal and child characteristics among 330 mother-child pairs in the EPOCH study, stratified by PNPLA3 rs738409 Genotype variant.

Author Contributions

K.S. designed the analysis, wrote the first draft of the article, and revised the article for important intellectual content. C.C.C. contributed to the conception and design of the analysis, aided in interpretation of data, and revised the article for important intellectual content. D.D. acquired the data, contributed to the design of the analysis, aided in data interpretation, and revised the article for important intellectual content. L.L. aided in interpretation of data and revised the article for important intellectual content. W.P. conceptualized and designed the study, contributed to the design of the analysis, and revised the article for important intellectual content. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the NIH, National Institute of Diabetes, Digestive, and Kidney Diseases (R01 DK068001). Perng is supported by ADA-7-22-ICTSPM-08. The funders had no role in the conceptualization, implementation, or interpretation of this work.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of The University of Colorado (COMIRB #05-0623; 31 October 2005).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author due to data restrictions.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
HFFHepatic Fat Fraction
MRIMagnetic Resonance Imaging
MASLDMetabolic Dysfunction-Associated Steatotic Liver Disease
EPOCHExploring Perinatal Outcomes Among CHildren
PCAPrincipal Component Analysis
RRRReduced-Rank Regression
FFQFood Frequency Questionnaire
GDMGestational Diabetes Mellitus
3DPAR3-Day Physical Activity Recall Questionnaire
METsMean Metabolic Equivalents
BMIBody Mass Index

References

  1. Fishman, J.; O’Connell, T.; Parrinello, C.M.; Woolley, J.J.; Bercaw, E.; Charlton, M.R. Prevalence of Nonalcoholic Steatohepatitis and Associated Fibrosis Stages Among US Adults Using Imaging-Based vs Biomarker-Based Noninvasive Tests. J. Health Econ. Outcomes Res. 2024, 11, 32–43. [Google Scholar] [CrossRef]
  2. Lee, H.S. Nonalcoholic fatty liver disease in children and adolescents. Clin. Exp. Pediatr. 2024, 67, 90–91. [Google Scholar] [CrossRef] [PubMed]
  3. Younossi, Z.M.; Henry, L. Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action. Diabetes Spectr. 2024, 37, 9–19. [Google Scholar] [CrossRef]
  4. Salari, N.; Darvishi, N.; Mansouri, K.; Ghasemi, H.; Hosseinian-Far, M.; Darvishi, F.; Mohammadi, M. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: A systematic review and meta-analysis. BMC Endocr. Disord. 2021, 21, 125. [Google Scholar] [CrossRef] [PubMed]
  5. NIDDK. Nonalcoholic Fatty Liver Disease (NAFLD) & NASH: Symptoms & Causes. 2021. Available online: https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/symptoms-causes (accessed on 5 December 2025).
  6. Juanola, O.; Martínez-López, S.; Francés, R.; Gómez-Hurtado, I. Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. Int. J. Environ. Res. Public Health 2021, 18, 5227. [Google Scholar] [CrossRef]
  7. Mirmiran, P.; Amirhamidi, Z.; Ejtahed, H.-S.; Bahadoran, Z.; Azizi, F. Relationship between Diet and Non-alcoholic Fatty Liver Disease: A Review Article. Iran. J. Public Health 2017, 46, 1007–1017. [Google Scholar]
  8. Papandreou, D.; Andreou, E. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World J. Hepatol. 2015, 7, 575–582. [Google Scholar] [CrossRef]
  9. Perng, W.; Harte, R.; Ringham, B.M.; Baylin, A.; Bellatorre, A.; Scherzinger, A.; Goran, M.I.; Dabelea, D. A Prudent dietary pattern is inversely associated with liver fat content among multi-ethnic youth. Pediatr. Obes. 2021, 16, e12758. [Google Scholar] [CrossRef]
  10. Cullen, K.W.; Watson, K.; Zakeri, I. Relative reliability and validity of the Block Kids Questionnaire among youth aged 10 to 17 years. J. Am. Diet. Assoc. 2008, 108, 862–866. [Google Scholar] [CrossRef]
  11. Haytowitz, D.B.; Ahuja, J.K.C.; Wu, X.; Somanchi, M.; Nickle, M.; Nguyen, Q.A.; Roseland, J.M.; Williams, J.R.; Patterson, K.Y.; Li, Y.; et al. USDA National Nutrient Database for Standard Reference, Legacy Release. 2019. Available online: https://data.nal.usda.gov/dataset/usda-national-nutrient-database-standard-reference-legacy-release (accessed on 4 December 2020).
  12. Willett, W.C. Implications of total energy intake for epidemiologic analyses. In Nutritional Epidemiology; Oxford University Press: New York, NY, USA, 1998; Volume 30, pp. 279–298. [Google Scholar]
  13. Nier, A.; Brandt, A.; Conzelmann, I.B.; Özel, Y.; Bergheim, I. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern. Nutrients 2018, 10, 1329. [Google Scholar] [CrossRef] [PubMed]
  14. Davis, J.N.; Lê, K.-A.; Walker, R.W.; Vikman, S.; Spruijt-Metz, D.; Weigensberg, M.J.; Allayee, H.; Goran, M.I. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am. J. Clin. Nutr. 2010, 92, 1522–1527. [Google Scholar] [CrossRef] [PubMed]
  15. Stanislawski, M.A.; Shaw, J.; Litkowski, E.; Lange, E.M.; Perng, W.; Dabelea, D.; Lange, L.A. Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study. J. Pediatr. 2020, 220, 146–153.e2. [Google Scholar] [CrossRef] [PubMed]
  16. Cohen, C.C.; Perng, W.; Sauder, K.A.; Ringham, B.M.; Bellatorre, A.; Scherzinger, A.; Stanislawski, M.A.; Lange, L.A.; Shankar, K.; Dabelea, D. Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren Study. J. Pediatr. 2021, 237, 50–58.e3. [Google Scholar] [CrossRef]
  17. Kahali, B.; Halligan, B.; Speliotes, E.K. Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease. Semin. Liver Dis. 2015, 35, 375–391. [Google Scholar] [CrossRef]
  18. American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care 2017, 40, S11–S24. [Google Scholar] [CrossRef]
  19. West, N.A.; Crume, T.L.; Maligie, M.A.; Dabelea, D. Cardiovascular risk factors in children exposed to maternal diabetes in utero. Diabetologia 2011, 54, 504–507. [Google Scholar] [CrossRef]
  20. de Onis, M.; Onyango, A.W.; Borghi, E.; Siyam, A.; Nishida, C.; Siekmann, J. Development of a WHO growth reference for school-aged children and adolescents. Bull. World Health Organ. 2007, 85, 660–667. [Google Scholar] [CrossRef]
  21. Marshall, W.A.; Tanner, J.M. Growth and physiological development during adolescence. Annu. Rev. Med. 1968, 19, 283–300. [Google Scholar] [CrossRef] [PubMed]
  22. Weston, A.T.; Petosa, R.; Pate, R.R. Validation of an instrument for measurement of physical activity in youth. Med. Sci. Sports Exerc. 1997, 29, 138–143. [Google Scholar] [CrossRef]
  23. Pate, R.R.; Ross, R.; Dowda, M.; Trost, S.G.; Sirard, J.R. Validation of a 3-Day Physical Activity Recall Instrument in Female Youth. Pediatr. Exerc. Sci. 2003, 15, 257–265. [Google Scholar] [CrossRef]
  24. Dunteman, G. Principal Components Analysis; SAGE Publications, Inc.: Newbury Park, CA, USA, 1989. [Google Scholar]
  25. McNaughton, S.A.; Ball, K.; Mishra, G.D.; Crawford, D.A. Dietary patterns of adolescents and risk of obesity and hypertension. J. Nutr. 2008, 138, 364–370. [Google Scholar] [CrossRef]
  26. McCann, S.E.; Marshall, J.R.; Brasure, J.R.; Graham, S.; Freudenheim, J.L. Analysis of patterns of food intake in nutritional epidemiology: Food classification in principal components analysis and the subsequent impact on estimates for endometrial cancer. Public Health Nutr. 2001, 4, 989–997. [Google Scholar] [CrossRef] [PubMed]
  27. Wang, D.; A Karvonen-Gutierrez, C.; Jackson, E.A.; Elliott, M.R.; Appelhans, B.M.; Barinas-Mitchell, E.; Bielak, L.F.; Huang, M.-H.; Baylin, A. Western Dietary Pattern Derived by Multiple Statistical Methods Is Prospectively Associated with Subclinical Carotid Atherosclerosis in Midlife Women. J. Nutr. 2020, 150, 579–591. [Google Scholar] [CrossRef] [PubMed]
  28. Della Corte, C.; Mosca, A.; Vania, A.; Alterio, A.; Iasevoli, S.; Nobili, V. Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study. Nutrition 2017, 39, 8–14. [Google Scholar] [CrossRef] [PubMed]
  29. Cakir, M.; Akbulut, U.E.; Okten, A. Association between Adherence to the Mediterranean Diet and Presence of Nonalcoholic Fatty Liver Disease in Children. Child. Obes. 2016, 12, 279–285. [Google Scholar] [CrossRef]
  30. Cook, L.T.; O’REilly, G.A.; Goran, M.I.; Weigensberg, M.J.; Spruijt-Metz, D.; Davis, J.N. Vegetable consumption is linked to decreased visceral and liver fat and improved insulin resistance in overweight Latino youth. J. Acad. Nutr. Diet. 2014, 114, 1776–1783. [Google Scholar] [CrossRef]
  31. Kim, S.-A.; Shin, S. Fruit and vegetable consumption and non-alcoholic fatty liver disease among Korean adults: A prospective cohort study. J. Epidemiol. Community Health 2020, 74, 1035–1042. [Google Scholar] [CrossRef]
  32. Hassani Zadeh, S.; Mansoori, A.; Hosseinzadeh, M. Relationship between dietary patterns and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J. Gastroenterol. Hepatol. 2021, 36, 1470–1478. [Google Scholar] [CrossRef]
  33. Shu, L.; Zhang, X.; Zhou, J.; Zhu, Q.; Si, C. Ultra-processed food consumption and increased risk of metabolic syndrome: A systematic review and meta-analysis of observational studies. Front. Nutr. 2023, 10, 1211797. [Google Scholar] [CrossRef]
  34. Lane, M.M.; Gamage, E.; Du, S.; Ashtree, D.N.; McGuinness, A.J.; Gauci, S.; Baker, P.; Lawrence, M.; Rebholz, C.M.; Srour, B.; et al. Ultra-processed food exposure and adverse health outcomes: Umbrella review of epidemiological meta-analyses. BMJ 2024, 384, e077310. [Google Scholar] [CrossRef]
  35. Costa de Miranda, R.; Rauber, F.; Levy, R.B. Impact of ultra-processed food consumption on metabolic health. Curr. Opin. Infect. Dis. 2021, 32, 24–37. [Google Scholar] [CrossRef]
  36. Mescoloto, S.B.; Pongiluppi, G.; Domene, S.M.Á. Ultra-processed food consumption and children and adolescents’ health. J. Pediatr. 2024, 100, S18–S30. [Google Scholar] [CrossRef]
  37. Mambrini, S.P.; Grillo, A.; Colosimo, S.; Zarpellon, F.; Pozzi, G.; Furlan, D.; Amodeo, G.; Bertoli, S. Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility. Front. Nutr. 2024, 11, 1426551. [Google Scholar] [CrossRef] [PubMed]
  38. Liu, C.; Liu, C.J. Effects of Exercise Intervention in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease. J. Obes. Metab. Syndr. 2025, 34, 239–252. [Google Scholar] [CrossRef]
  39. Neta, A.D.C.P.A.; Steluti, J.; Ferreira, F.E.L.L.; Farias Junior, J.C.; Marchioni, D.M.L. Dietary patterns among adolescents and associated factors: Longitudinal study on sedentary behavior, physical activity, diet and adolescent health. Cienc. Saude Coletiva 2021, 26, 3839–3851. [Google Scholar] [CrossRef] [PubMed]
  40. Eck, K.M.; Byrd-Bredbenner, C. Food Choice Decisions of Collegiate Division I Athletes: A Qualitative Exploratory Study. Nutrients 2021, 13, 2322. [Google Scholar] [CrossRef] [PubMed]
  41. Milanović, M.; Milošević, N.; Ružić, M.; Abenavoli, L.; Milić, N. Whey Proteins and Metabolic Dysfunction-Associated Steatotic Liver Disease Features: Evolving the Current Knowledge and Future Trends. Metabolites 2025, 15, 516. [Google Scholar] [CrossRef]
  42. Wagenknecht, L.E.; Palmer, N.D.; Bowden, D.W.; Rotter, J.I.; Norris, J.M.; Ziegler, J.; Chen, Y.-D.I.; Haffner, S.; Scherzinger, A.; Langefeld, C.D. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: The Insulin Resistance Atherosclerosis Family Study. Liver Int. 2011, 31, 412–416. [Google Scholar] [CrossRef]
  43. Chinchilla-López, P.; Ramírez-Pérez, O.; Cruz-Ramón, V.; Canizales-Quinteros, S.; Domínguez-López, A.; Ponciano-Rodríguez, G.; Sánchez-Muñoz, F.; Méndez-Sánchez, N. More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3. Ann. Hepatol. 2018, 17, 250–255. [Google Scholar] [CrossRef]
  44. Romeo, S.; Kozlitina, J.; Xing, C.; Pertsemlidis, A.; Cox, D.; Pennacchio, L.A.; Boerwinkle, E.; Cohen, J.C.; Hobbs, H.H. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 2008, 40, 1461–1465. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  45. Schenker, R.B.; Machle, C.J.; Schmidt, K.A.; Allayee, H.; Kohli, R.; Goran, M.I. Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity. Liver Int. 2024, 44, 1768–1774. [Google Scholar] [CrossRef] [PubMed]
  46. Schmidt, K.A.; Jones, R.B.; Rios, C.; Corona, Y.; Berger, P.K.; Plows, J.F.; Alderete, T.L.; Fogel, J.; Hampson, H.; Hartiala, J.A.; et al. Clinical Intervention to Reduce Dietary Sugar Does Not Affect Liver Fat in Latino Youth, Regardless of PNPLA3 Genotype: A Randomized Controlled Trial. J. Nutr. 2022, 152, 1655–1665. [Google Scholar] [CrossRef] [PubMed]
  47. Hanssen, H.; Hauser, C. Childhood risk trajectories into adulthood: Fit for future? Eur. J. Prev. Cardiol. 2025, zwaf249. [Google Scholar] [CrossRef] [PubMed]
Table 1. % (N) for maternal perinatal and child characteristics among 381 mother–child pairs in the EPOCH study.
Table 1. % (N) for maternal perinatal and child characteristics among 381 mother–child pairs in the EPOCH study.
% (N) a
Maternal perinatal characteristics
Maternal pre-pregnancy body mass index (BMI; kg/m2)
 Underweight (<18.5 kg/m2)3.4% (9)
 Normal weight (18.5–24.9 kg/m2)48.3% (130)
 Overweight (25.0–29.9 kg/m2)27.5% (74)
 Obese (>30 kg/m2)20.8% (56)
Maternal gestational diabetes mellitus
 Yes17.4% (66)
 No82.6% (314)
Annual household income
 <$25,0008.2% (31)
$25,000–$49,99935.8% (136)
 >$50,00056.1% (213)
Maternal education
 <High school3.2% (12)
 High school or equivalent14.4% (55)
 >High school82.4% (314)
Mother smoked during pregnancy
 Yes7.4% (28)
 No92.7% (28)
Offspring sex
 Female50.4% (192)
 Male49.6% (189)
Offspring race/ethnicity
 Non-Hispanic White52.0% (198)
 Hispanic36.0% (137)
 Non-Hispanic Black7.4% (28)
 Non-Hispanic Other4.7% (18)
Offspring characteristics at the adolescent visit
Age
 12 to <16 years26.8% (102)
 16 to <17 years29.1% (111)
 ≥17 years44.1% (168)
BMI z-score b
 <−2.02.1% (8)
 ≥−2.0 to ≤1.067.2% (256)
 >1.0 to ≤2.023.1% (88)
 >2.07.6% (29)
Pubertal status c
 Tanner stage 10.0% (0)
 Tanner stage 20.8% (3)
 Tanner stage 35.0% (19)
 Tanner stage 4 or 594.2% (359)
a Totals may not add up to 381 due to missing values. b According to the World Health Organization (WHO) growth reference for children 5 to 19 years of age. c Based on pubic hair development in boys and breast development in girls.
Table 2. Bivariate associations of background characteristics with hepatic fat fraction among 381 mother–child pairs in the EPOCH study.
Table 2. Bivariate associations of background characteristics with hepatic fat fraction among 381 mother–child pairs in the EPOCH study.
N aHepatic Fat Fractionp b
3812.47 ± 3.11
Range: 0–38.21
Maternal perinatal characteristics
Maternal pre-pregnancy body mass index (BMI; kg/m2) 0.0001
 Underweight (<18.5 kg/m2)92.19 ± 0.90
 Normal weight (18.5–24.9 kg/m2)1301.89 ± 1.17
 Overweight (25.0–29.9 kg/m2)742.56 ± 2.20
 Obese (>30 kg/m2)563.78 ± 5.69
Maternal gestational diabetes mellitus 0.34
 Yes662.80 ± 4.72
 No3142.40 ± 2.67
Annual household income 0.02
 <$25,000313.74 ± 5.57
$25,000–$49,9991362.54 ± 3.52
 >$50,0002132.24 ± 2.19
Maternal education 0.87
 <High school122.60 ± 2.18
 High school or equivalent552.50 ± 2.33
 >High school3142.46 ± 3.27
Mother smoked during pregnancy 0.54
 Yes282.81 ± 5.59
 No3532.44 ± 2.84
Offpsing sex 0.16
 Female1922.24 ± 2.22
 Male1892.70 ± 3.81
Offspring race/ethnicity 0.18
 Non-Hispanic White1982.00 ± 1.33
 Hispanic1373.27 ± 4.80
 Non-Hispanic Black282.26 ± 1.31
 Non-Hispanic Other181.89 ± 0.93
Offspring characteristics at the adolescent visit
Age 0.23
 12 to <16 years1023.06 ± 4.02
 16 to <17 years1111.92 ± 1.37
 ≥17 years1682.47 ± 3.26
BMI z-score c <0.0001
 <−2.081.93 ± 1.10
 ≥−2.0 to ≤1.02561.79 ± 1.01
 >1.0 to ≤2.0883.16 ± 4.35
 >2.0296.48 ± 6.39
Pubertal status d 0.0001
 Tanner stage 10
 Tanner stage 2314.66 ± 20.40
 Tanner stage 3191.93 ± 0.93
 Tanner stage 4 or 53592.40 ± 2.58
METs over a 3-day period 0.73
 Q1 (lowest)902.68 ± 2.90
 Q2942.35 ± 1.73
 Q3972.48 ± 3.90
 Q4 (highest)912.46 ± 3.62
a Totals may not add up to 381 due to missing values. b From a p for linear trend for ordinal variables; from a Type 3 test for a difference for categorical variables (child sex only). c According to the World Health Organization (WHO) growth reference for children 5 to 19 years of age. d Based on pubic hair development in boys and breast development in girls. Bolded values indicate statistical significance at alpha = 0.05.
Table 3. Top-loading food groups from principal component analysis (PCA) and reduced-rank regression (RRR) during the adolescent visit (median age 16 years, range 12–19 years).
Table 3. Top-loading food groups from principal component analysis (PCA) and reduced-rank regression (RRR) during the adolescent visit (median age 16 years, range 12–19 years).
Food GroupPCARRR
Factor 1: PrudentFactor 2: WesternFactor 1: Prudent
Leafy greens68
Vegetables68 * −27 *
Fruit58 * −21 *
Cruciferous vegetables46
Nuts and seeds46 * −25 *
Yogurt44
Vegetable stir fry4021
Granola bars32
Oatmeal32 * −20 *
Sports bars29 * −28 *
Beans27
Fish26
Crackers and sandwiches24 * −32 *
Eggs23
Cheese23
Potatoes and sweet potatoes22
Dried fruit22
Veggie or beef soup20
High-fat sandwich or wrap−2622
Margarine, butter, or lard−34
Sugar-sweetened beverages−35
Fried potatoes−2558
Ketchup 52
Beef−36 *44 *25 *
Fast food−3542
Salad dressing3841
High-fat snacks 36
Candy2233
Ice cream 30
Dessert 23−20
Chicken 23
Pork 21
Milk −33
Cereal −45
Fruit juice −21
High-fat sides 20
Bolded columns with asterisks indicate the food groups that were included in the diet score.
Table 4. Associations (β [95% CI] or OR [95% CI]) of diet score with hepatic fat among 381 youth in the EPOCH study during the adolescent visit (median age 16 years, range 12–19 years).
Table 4. Associations (β [95% CI] or OR [95% CI]) of diet score with hepatic fat among 381 youth in the EPOCH study during the adolescent visit (median age 16 years, range 12–19 years).
Diet Score, per 1 SD
ModelModel NHepatic Fat Fraction (%): β (95% CI)Elevated Hepatic Fat Fraction Yes/No: OR (95% CI)
UnadjustedN = 381−0.51 (−0.82, −0.20)0.47 (0.28, 0.79)
Model 1N = 380−0.48 (−0.80, −0.16)0.46 (0.27, 0.78)
Model 2N = 379−0.48 (−0.81, −0.16)0.46 (0.27, 0.79)
Model 3N = 380−0.39 (−0.69, −0.10)0.49 (0.28, 0.88)
Bolded values indicate statistical significance at alpha = 0.05. Model 1: Adjusted for child sex and age. Model 2: Model 1 + in utero exposure to maternal GDM, maternal education level, and prenatal smoking habits. Model 3: Model 1 + child BMI z-score and Tanner stage.
Table 5. Associations (β [95% CI] or OR [95% CI]) of diet z-score with hepatic fat stratified by PNPLA3 rs738409 genotype among 330 youth in the EPOCH study at ages 12–19 years.
Table 5. Associations (β [95% CI] or OR [95% CI]) of diet z-score with hepatic fat stratified by PNPLA3 rs738409 genotype among 330 youth in the EPOCH study at ages 12–19 years.
PNPLA3 rs738409 Genotype
CC (Wild-Type)
N = 175
CG (Intermediate)
N = 125
GG (High-Risk)
N = 30
Diet z-Score, per 1 SD
Hepatic fat fraction (%): β (95% CI)
Unadjusted−0.32 (−0.77, 0.13)−0.43 (−0.77, −0.10)−2.19 (−4.35, −0.03)
Model 1−0.23 (−0.69, 0.22)−0.44 (−0.81, −0.08)−1.76 (−4.10, 0.57)
Model 2−0.25 (−0.70, 0.20)−0.37 (−0.74, −0.00)−1.33 (−3.55, 0.88)
Elevated hepatic fat fraction yes/no: OR (95% CI)
Unadjusted0.62 (0.26, 1.49)0.61 (0.28, 1.34)0.10 (0.01, 0.84)
Model 10.71 (0.29, 1.70)0.55 (0.23, 1.29)0.09 (0.01, 0.99)
Model 20.70 (0.29, 1.70)0.68 (0.28, 1.65)0.05 (0.00, 1.03)
Bolded values indicate statistical significance at alpha = 0.05. Model 1: Adjusted for child sex and age. Model 2: Model 1 + in utero exposure to maternal GDM, maternal education level, and prenatal smoking habits.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Salmon, K.; Cohen, C.C.; Lange, L.; Dabelea, D.; Perng, W. Dietary Patterns, Hepatic Fat Fraction, and the Role of Genotype. Nutrients 2026, 18, 1087. https://doi.org/10.3390/nu18071087

AMA Style

Salmon K, Cohen CC, Lange L, Dabelea D, Perng W. Dietary Patterns, Hepatic Fat Fraction, and the Role of Genotype. Nutrients. 2026; 18(7):1087. https://doi.org/10.3390/nu18071087

Chicago/Turabian Style

Salmon, Kyle, Catherine C. Cohen, Leslie Lange, Dana Dabelea, and Wei Perng. 2026. "Dietary Patterns, Hepatic Fat Fraction, and the Role of Genotype" Nutrients 18, no. 7: 1087. https://doi.org/10.3390/nu18071087

APA Style

Salmon, K., Cohen, C. C., Lange, L., Dabelea, D., & Perng, W. (2026). Dietary Patterns, Hepatic Fat Fraction, and the Role of Genotype. Nutrients, 18(7), 1087. https://doi.org/10.3390/nu18071087

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop